{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:49:55Z","timestamp":1745470195239,"version":"3.37.3"},"reference-count":19,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>We present a non-consanguineous family of three siblings who presented with diabetes mellitus (DM), two of whom had genetically confirmed cystic fibrosis (CF), with one pancreatic-sufficient mutation in the cystic fibrosis transmembrane conductance regulator (<jats:italic>CFTR<\/jats:italic>) gene (\u0394F508\/R117H;IVS8-5T). A detailed history revealed family members from three successive generations diagnosed with \u2018type 1\u2019 or \u2018type 2\u2019 diabetes, leading to genetic investigations for monogenic DM. A heterozygous frameshift mutation in the hepatocyte nuclear factor 1 homeobox alpha (<jats:italic>HNF1A<\/jats:italic>) gene (c.404delA) was subsequently confirmed in all three siblings, which is known to cause monogenic diabetes and is exquisitely sensitive to sulfonylurea therapy. Following this diagnosis, both siblings with CF and <jats:italic>HNF1A<\/jats:italic> monogenic diabetes were started on gliclazide therapy, while their older brother who had been wrongly diagnosed with type 1 diabetes was switched from insulin to gliclazide, all with excellent therapeutic responses.<\/jats:p>","DOI":"10.1136\/archdischild-2018-316141","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T16:19:25Z","timestamp":1538237965000},"page":"887-889","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Monogenic diabetes mellitus in cystic fibrosis"],"prefix":"10.1136","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-0397","authenticated-orcid":false,"given":"Hoong-Wei","family":"Gan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0083-7460","authenticated-orcid":false,"given":"Jayesh Mahendra","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Denvir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabitha","family":"Randell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,9,29]]},"reference":[{"key":"2020050712501081000_104.9.887.1","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.ejim.2017.03.011","article-title":"Epidemiology of cystic fibrosis-related diabetes in Madrid (Spain) and frequency of hospitalization","volume":"42","author":"Zoni","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2020050712501081000_104.9.887.2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.66.5.612"},{"key":"2020050712501081000_104.9.887.3","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0586"},{"key":"2020050712501081000_104.9.887.4","doi-asserted-by":"crossref","unstructured":"Scheuing N , Holl RW , Dockter G , et al . Diabetes in cystic fibrosis: multicenter screening results based on current guidelines. PLoS One 2013;8:e81545.doi:10.1371\/journal.pone.0081545","DOI":"10.1371\/journal.pone.0081545"},{"key":"2020050712501081000_104.9.887.5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13023-017-0694-1","article-title":"What can the CF registry tell us about rare CFTR-mutations? A Belgian study","volume":"12","author":"De Wachter","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2020050712501081000_104.9.887.6","unstructured":"The Clinical and Functional TRanslation of CFTR (CFTR2. Baltimore, MD, USA: US Cystic Fibrosis Foundation, Johns Hopkins University, The Hospital for Sick Children, 2011."},{"key":"2020050712501081000_104.9.887.7","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1958.02060060008002"},{"key":"2020050712501081000_104.9.887.8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.49.9.860"},{"key":"2020050712501081000_104.9.887.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2418-8"},{"key":"2020050712501081000_104.9.887.10","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0859"},{"key":"2020050712501081000_104.9.887.11","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22279"},{"key":"2020050712501081000_104.9.887.12","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.2337\/diabetes.50.2007.S94","article-title":"beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors","volume":"50 Suppl 1","author":"Frayling","year":"2001","journal-title":"Diabetes"},{"key":"2020050712501081000_104.9.887.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2008.03.009"},{"key":"2020050712501081000_104.9.887.14","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1992.02160240067022"},{"key":"2020050712501081000_104.9.887.15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pedi.12178","article-title":"ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents","volume":"15 Suppl 20","author":"Moran","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"2020050712501081000_104.9.887.16","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0778"},{"key":"2020050712501081000_104.9.887.17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1089769"},{"key":"2020050712501081000_104.9.887.18","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.4.583"},{"key":"2020050712501081000_104.9.887.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14571-0"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-316141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:14:52Z","timestamp":1601072092000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-316141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,29]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,8,16]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/archdischild-2018-316141"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-316141","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"type":"print","value":"0003-9888"},{"type":"electronic","value":"1468-2044"}],"subject":[],"published":{"date-parts":[[2018,9,29]]}}}